A detailed history of Paces Ferry Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Paces Ferry Wealth Advisors, LLC holds 3,312 shares of NVO stock, worth $281,520. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,312
Previous 3,332 0.6%
Holding current value
$281,520
Previous $475,000 17.05%
% of portfolio
0.23%
Previous 0.29%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.07 - $145.42 $2,381 - $2,908
-20 Reduced 0.6%
3,312 $394,000
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $9,325 - $11,165
-76 Reduced 2.23%
3,332 $475,000
Q1 2024

May 01, 2024

SELL
$102.11 - $135.92 $17,562 - $23,378
-172 Reduced 4.8%
3,408 $437,000
Q4 2023

Feb 05, 2024

SELL
$87.78 - $105.45 $1,228 - $1,476
-14 Reduced 0.39%
3,580 $370,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $158,508 - $347,798
1,743 Added 94.17%
3,594 $326,000
Q2 2023

Jul 28, 2023

SELL
$155.98 - $172.65 $1,247 - $1,381
-8 Reduced 0.43%
1,851 $299,000
Q1 2023

Apr 24, 2023

SELL
$132.34 - $159.14 $3,705 - $4,455
-28 Reduced 1.48%
1,859 $295,000
Q4 2022

Jan 23, 2023

BUY
$102.55 - $135.33 $193,511 - $255,367
1,887 New
1,887 $0
Q2 2022

Jul 28, 2022

BUY
$103.24 - $121.81 $2,581 - $3,045
25 Added 1.34%
1,894 $211,000
Q1 2022

Apr 20, 2022

SELL
$93.1 - $112.54 $8,751 - $10,578
-94 Reduced 4.79%
1,869 $208,000
Q4 2021

Jan 19, 2022

BUY
$95.88 - $117.08 $188,212 - $229,828
1,963 New
1,963 $220,000
Q4 2020

Mar 05, 2021

SELL
$63.89 - $73.8 $141,771 - $163,762
-2,219 Closed
0 $0
Q3 2020

Nov 19, 2020

BUY
$63.69 - $70.22 $141,328 - $155,818
2,219 New
2,219 $154,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Paces Ferry Wealth Advisors, LLC Portfolio

Follow Paces Ferry Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paces Ferry Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paces Ferry Wealth Advisors, LLC with notifications on news.